Morgan Stanley Trims Earnings Estimates for BUD APAC, Keeps Overweight Rating and HK$9 Target

Stock News
02/16

Morgan Stanley has incorporated BUD APAC's 2025 results and 2026 guidance into its forecasts. The firm has lowered its profit estimates for the company for the current and next fiscal years by 12% and 14%, respectively. Morgan Stanley introduced an earnings per share forecast of 6 cents for BUD APAC for 2028. It maintained an "Overweight" rating on the stock and extended its valuation base to 2026, keeping the target price at HK$9.

Due to an increased proportion of at-home consumption channels in China, the firm has reduced its average selling price forecast for 2026-2027 by 2% to 3%. This adjustment led to a decrease in the gross margin forecast for 2026 and 2027 by 1.1 and 2 percentage points, respectively. Morgan Stanley also raised its forecast for the sales, general, and administrative expense ratio, reflecting investments related to the channel shift in China and commercial investments in eastern and western regions.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10